FDA Allows Vytorin Labeling for Use in Kidney Disease
(medpagetoday.co) (MedPage Today) -- The FDA has approved new labeling for the single-tablet combination of ezetimibe-simvastatin (Vytorin), a cholesterol-lowering drug, for use in patients with moderate to severe chronic kidney disease.
Update update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 15786 failed: 1142 [UPDATE command denied to user '334187_hdlns_ms5'@'10.187.248.89' for table 'feed'] in [update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 15786]
updated 15786 (Medical - Nephrology), inserted 15, updated 0, at 2012-05-31 07:09:00
Articles from: Medical - Nephrology (medpagetoday.co)